Asarfi Hospital Ltd (ASARFI.BO)

Healthcare | Medical Care Facilities
Income Statement (Quarterly) 2026-04-06 2025-09-30 2025-06-30 2024-12-31
Revenue 713,622,000 713,622,000 356,811,000 328,901,000
Cost of Revenue 171,476,000 171,476,000 85,738,000 71,811,000
Gross Profit 542,146,000 542,146,000 271,073,000 257,090,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 0 0 0 0
Operating Expenses 462,174,000 462,174,000 231,087,000 218,043,000
Operating Income 79,972,000 79,972,000 39,986,000 39,047,000
Interest Expense 24,376,000 24,376,000 12,188,000 11,750,000
Income Before Tax 83,922,000 83,922,000 41,961,000 36,244,000
Income Tax Expense 21,500,000 21,500,000 10,750,000 9,396,000
Net Income 62,422,000 62,422,000 31,211,000 26,849,000
Per Share
EPS 3.18 3.18 1.59 1.36
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31
Revenue 1,205,657,000 844,004,000
Cost of Revenue 278,592,000 203,315,000
Gross Profit 927,065,000 640,689,000
Operating Expenses
R&D Expenses 0 0
SG&A Expenses 0 178,847,000
Operating Expenses 818,344,000 566,442,000
Operating Income 108,721,000 74,247,000
Interest Expense 40,809,000 24,407,000
Income Before Tax 143,111,000 62,910,000
Income Tax Expense 37,348,000 21,294,000
Net Income 105,762,000 41,616,000
Per Share
EPS 5.36 2.31
EPS Diluted 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31
Assets
Cash and Cash Equivalents 14,263,000 175,955,000
Short Term Investments 0 0
Net Receivables 406,734,000 242,824,000
Inventory 22,767,000 17,999,000
Total Current Assets 584,844,000 467,524,000
Property Plant Equipment 1,035,835,000 937,664,000
Goodwill and Intangibles 0 0
Total Assets 1,638,867,000 1,540,882,000
Liabilities
Account Payables 130,357,000 248,574,000
Short Term Debt 147,280,000 115,908,000
Total Current Liabilities 410,392,000 414,797,000
Long Term Debt 338,293,000 203,214,000
Total Liabilities 829,035,000 836,812,000
Shareholders Equity
Retained Earnings 0 247,929,000
Total Shareholders Equity 809,832,000 704,070,000
Balance Sheet (Annual) 2025-03-31 2024-03-31
Assets
Cash and Cash Equivalents 14,263,000 175,955,000
Short Term Investments 0 0
Net Receivables 406,734,000 242,824,000
Inventory 22,767,000 17,999,000
Total Current Assets 584,844,000 467,524,000
Property Plant Equipment 1,035,835,000 937,664,000
Goodwill and Intangibles 0 0
Total Assets 1,638,867,000 1,540,882,000
Liabilities
Account Payables 130,357,000 248,574,000
Short Term Debt 147,280,000 115,908,000
Total Current Liabilities 410,392,000 414,797,000
Long Term Debt 338,293,000 203,214,000
Total Liabilities 829,035,000 836,812,000
Shareholders Equity
Retained Earnings 0 247,929,000
Total Shareholders Equity 809,832,000 704,070,000
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31
Operating Activities
Net Income 105,762,000 41,616,000
Depreciation & Amortization 126,760,000 87,875,000
Stock Based Compensation 0 0
Change in Working Capital -278,037,000 -106,394,000
Operating Cash Flow -43,498,000 260,741,000
Investing Activities
Capital Expenditure -117,872,000 -460,739,000
Investments -117,872,000 -460,739,000
Investing Cash Flow -73,839,000 -630,899,000
Financing Activities
Debt Repayment 166,451,000 147,102,000
Common Stock Issued/Repurchased 0 231,027,000
Dividends Paid 0 0
Financing Cash Flow 125,688,000 364,068,000
Summary
Free Cash Flow -161,370,000 -199,998,000
Net Change in Cash 8,351,000 -6,090,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31
Operating Activities
Net Income 105,762,000 41,616,000
Depreciation & Amortization 126,760,000 87,875,000
Stock Based Compensation 0 0
Change in Working Capital -278,037,000 -106,394,000
Operating Cash Flow -43,498,000 260,741,000
Investing Activities
Capital Expenditure -117,872,000 -460,739,000
Investments -117,872,000 -460,739,000
Investing Cash Flow -73,839,000 -630,899,000
Financing Activities
Debt Repayment 166,451,000 147,102,000
Common Stock Issued/Repurchased 0 231,027,000
Dividends Paid 0 0
Financing Cash Flow 125,688,000 364,068,000
Summary
Free Cash Flow -161,370,000 -199,998,000
Net Change in Cash 8,351,000 -6,090,000